COMMUNIQUÉS West-GlobeNewswire

Progenics Pharmaceuticals Sets Fourth Quarter and Full-Year 2018 Financial Results and Business Update Call for March 14
07/03/2019
NEW YORK, March 07, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing innovative medicines and imaging analysis technology for targeting and treating cancer, today [...]
Cytori Files Pre-submission Request for New Drug Application
07/03/2019
Doxorubicin Hydrochloride Cytori - First Intended for European Market SAN DIEGO, March 07, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) today announced that it officially filed a formal new drug [...]
Quotient Limited to Participate in the Cowen and Company 39th Annual Health Care Conference
07/03/2019
JERSEY, Channel Islands, March 07, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company’s Chief Financial Officer, Chris Lindop, will present [...]
For The Earth Announces Launch of New Line of Premium CBD-Infused Topicals
07/03/2019
PHOENIX, March 07, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- For The Earth Corporation (the "Company" or "FTEG") (OTCMKTS: FTEG) is thrilled to announce the launch of its new line of premium pharmaceutical grade anti- [...]
Trinity Biotech announces Quarter 4 and Fiscal Year 2018 Financial Results
07/03/2019
DUBLIN, Ireland, March 07, 2019 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced [...]
Wishbone Medical Breaks Ground With Foot & Ankle Solutions for Children
07/03/2019
New technology optimized by sterile, single-use packaging WARSAW, Ind., March 07, 2019 (GLOBE NEWSWIRE) -- WishBone Medical expands the pediatric orthopedic market with leading edge foot and ankle solutions in sterile, [...]
Vystar Gains 1st Institutional Investor with $200K Investment at $0.15/Share
07/03/2019
WORCESTER, Mass., March 07, 2019 (GLOBE NEWSWIRE) -- Vystar Corporation , (OTC Pink: VYST) a family of eco-friendly brands including Vytex® Natural Rubber Latex (NRL) and RxAir® air purification products, announced that [...]
Auris Medical to Report Fourth Quarter and Full Year 2018 Financial Results and Provide Business Update on Thursday, March 14, 2019
07/03/2019
Zug, Switzerland, March 07, 2019 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous [...]
Allena Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
07/03/2019
-- Achieved Alignment with U.S. Food and Drug Administration (FDA) on Phase 3 URIROX TM Program and Accelerated Approval Strategy for Reloxaliase -- -- Phase 3 URIROX-1 and URIROX-2 Trials Ongoing; URIROX-1 Topline Data [...]
Catalyst Biosciences Reports Fourth Quarter and Full-Year 2018 Operating & Financial Results and Provides a Corporate Update
07/03/2019
Completed enrollment of the MarzAA SQ Phase 2 trial and demonstrated safety and clinical efficacy, with >90% reduction in bleeding Completed a full immunogenicity analysis for DalcA, plan to initiate a Phase 2b 28- [...]
Seelos Therapeutics Announces Acquisition of an Exclusive License to Intellectual Property from The UC Regents to Potential Disease-Modifying Parkinson's Disease Therapy Created at UCLA
07/03/2019
Well-Validated, Pre-Clinical Success Shown in the Reduction of Alpha-Synuclein New Compound Expands Seelos’ Parkinson's Portfolio NEW YORK, March 07, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (NASDAQ: SEEL), a [...]
Avadel Pharmaceuticals to Report Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
DUBLIN, Ireland, March 07, 2019 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218 for sleep disorders, today announced that it will host a conference call and live [...]
Neos Therapeutics to Host Fourth Quarter and Year-End 2018 Financial and Operating Results Conference Call on March 14th, 2019
07/03/2019
DALLAS and FORT WORTH, Texas, March 07, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR [...]
Foamix Announces FDA Acceptance of New Drug Application for FMX101 Minocycline Foam for the Treatment of Moderate-to-Severe Acne
07/03/2019
PDUFA Target Action Date of October 20th, 2019 REHOVOT, Israel, and BRIDGEWATER, N.J., March 07, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a clinical stage specialty pharmaceutical company [...]
AMAG Pharmaceuticals Presents New Data on Bremelanotide and Hypoactive Sexual Desire Disorder at the ISSWSH/ISSM Joint Meeting
07/03/2019
WALTHAM, Mass., March 07, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today that new and encore data related to bremelanotide and Hypoactive Sexual Desire Disorder (HSDD) will be [...]
TYME Continues to Expand Pipeline of Cancer Metabolism-Based Therapies to Potentially Benefit Patients with Difficult-to-Treat Cancers
07/03/2019
Targeting IND-enabling program for TYME-18 in 2H2019 NEW YORK, March 07, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME) , an emerging biotechnology company developing cancer metabolism-based therapies ( [...]
Aduro Biotech to Present at Two Upcoming Investor Conferences in March
07/03/2019
BERKELEY, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that Aduro management is scheduled to present at the following investor conferences: 39 th Annual Cowen Health Care [...]
Zafgen to Present at the Cowen and Company 39th Annual Health Care Conference
07/03/2019
BOSTON, March 07, 2019 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients [...]
Samumed to Present Clinical Data on SM04690 at the American Academy of Orthopaedic Surgeons 2019 Annual Meeting
07/03/2019
SAN DIEGO, March 07, 2019 (GLOBE NEWSWIRE) -- Samumed, LLC, announced today that clinical data from its successful phase 2a trial of SM04690 for the treatment of knee osteoarthritis (OA) has been accepted as a poster [...]

Pages